


Childhood Apraxia of Speech-Symptoms, treatments, exercises

Childhood apraxia of speech (CAS) is a neurological disorder that affects an individual’s ability to produce speech sounds accurately and fluently. CAS is caused by difficulty planning and coordinating the muscle movements needed for speech, and is not caused by weakness or paralysis of the muscles used for speech.
Symptoms of CAS may include:
- Difficulty producing sounds: Children with CAS may have difficulty producing certain sounds or may not be able to say words or sounds correctly.
- Difficulty with the rhythm and flow of speech: Children with CAS may have difficulty with the rhythm and flow of speech, and may have a choppy or halting speech pattern.
- Difficulty with language skills: Children with CAS may have difficulty with language skills, such as understanding and using words and sentences.
Treatment of CAS
CAS can affect children of any age and can range in severity. Treatment for CAS typically involves speech therapy, which can help children improve their speech production skills and develop more effective communication strategies. In some cases, medications may be used to help manage specific symptoms of CAS, such as anxiety or hyperactivity. It is important to note that treatment for CAS is typically tailored to the individual’s specific needs and may involve a combination of therapies and interventions. A healthcare professional, such as a speech therapist or psychologist, can help develop an appropriate treatment plan.
Treatment for childhood apraxia of speech (CAS) typically involves speech therapy, which can help children improve their speech production skills and develop more effective communication strategies. The goals of speech therapy for CAS may include:
- Improving speech sound production: Speech therapy can help children with CAS learn to produce speech sounds more accurately and fluently. This may involve activities and exercises to help improve muscle control and coordination.
- Improving language skills: Speech therapy can also help children with CAS improve their language skills, such as understanding and using words and sentences.
- Developing compensatory strategies: Speech therapy can help children with CAS develop compensatory strategies, such as using gestures or visual aids, to help them communicate more effectively.
Here are a few exercises that may be beneficial for a child with Childhood Apraxia of Speech (CAS):
- Articulation exercises: Children with CAS often struggle with the physical movements needed to produce speech sounds correctly. Exercises that focus on the muscles of the face and mouth, such as blowing bubbles, blowing through a straw, or blowing up balloons, can help to improve the child’s ability to coordinate the movement of their speech muscles.
- Repetition exercises: Children with CAS may benefit from repeating words and phrases to improve their ability to coordinate the movements needed for speech. This can be done by repeating simple words or phrases, such as “mom” or “I want juice,” in isolation or in short phrases or sentences.
- Imitation exercises: Children with CAS may benefit from imitating the speech of others. The child can watch or listen to a model speak and then imitate what they hear. This can help to improve the child’s ability to coordinate the movements needed for speech.
- Auditory bombardment: The child listen to different words and phrases repeatedly, which exposes them to a wide range of sounds and words, which helps them in their development of speech sounds.
- Tactile cueing: Children with CAS may benefit from having a tactile cue to remind them of the correct position of the articulators. This can be done by placing an object such as a popsicle stick in the child’s mouth to remind them of the correct position for speech sounds.
- Motor planning exercises: Children with CAS struggle with planning and coordinating the muscle movements required for speech, so exercises that target this area can be helpful. this can be done by asking child to move their body in specific ways while they are saying a word or phrase, such as making big arm movements while saying the word “big” or touching their nose while saying “nose.”
Resources
- m B-R, SeoH-S, Ku J-M, et al. Silibinininhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast-cells. Inflammation. Research. 2013;62(11):941-950. doi:10.1007/s00011-013-0640-1.
- ChapowalA. PetasitesStudy Group. Randomisedcontrolled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. BMJ 2002;324:144-6.
- Hayes, N. A. and Foreman, J. C. The activity of compounds extracted from feverfew on histamine release from rat mast-cells. J Pharm Pharmacol1987;39(6):466-470
- Hsieh et al. Baicalein inhibits IL-1ß- and TNF-a-induced inflammatory cytokine production from human mast-cells via regulation of the NF-?B pathway. ClinMolAllergy. 5: 5. 2007.
- TheoharidesTC, Patra P, Boucher W, et al. Chondroitin sulphateinhibits connective tissue mast-cells. British Journal of Pharmacology. 2000;131(6):1039-1049. doi:10.1038/ sj.bjp.0703672.
- Ro JY, Lee BC, Kim JY, et al. Inhibitory mechanism of aloe single component (alprogen) on mediator release in guinea pig lung mast-cells activated with specific antigenantibodyreactions. J PharmacolExpTher. 2000;292:114–121. 73.
- https://www.ncbi.nlm.nih.gov/pubmed/24477254
- https://www.ncbi.nlm.nih.gov/pubmed/28458279
- https://www.ncbi.nlm.nih.gov/pubmed/9421440
- https://www.ncbi.nlm.nih.gov/pubmed/10344773
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315779/

Auditory Processing Disorder – What Is It and How Can You Help Your Child?

The Association of Social and Cognitive Impairment With Biomarkers in Autism Spectrum Disorders

Mitochondrial Dysfunction: The Role of Nutritional Supplementation

The Relationship Between Autism and Mitochondrial Dysfunction

Mitochondrial disorders

While the exact causes of autism are still unknown, researchers have recently uncovered a mysterious link between autism and mitochondrial disorders. Mitochondrial disorders are caused by mutations in the mitochondria, which are the parts of our cells that produce energy, and can lead to a wide range of symptoms. This link has made it possible to identify and treat some cases of autism, offering hope to those affected by this condition. In this blog post, we’ll discuss the intriguing connection between autism and mitochondrial disorders and what this could mean for those living with autism.
Mitochondria
Mitochondrial disorder
Mitochondrial disorders are a group of complex and potentially life-threatening illnesses caused by mutations in the mitochondrial DNA. Mitochondria are tiny organelles found inside our cells that play a key role in energy production. They convert energy from food into a form that our bodies can use to function normally.
Sympoms of mitochondrial dysfunction
The most common symptoms are fatigue, but brain fog is also common when the mitochondria in the brain are not working properly.
Other symptoms may include:
- pain
- mood disorders
- anxiety
- depression
- concentration disorder
Most chronic diseases/conditions are also linked to mitochondrial dysfunction, such as:
- cardiovascular diseases
- lung disease
- vision and hearing problems
- learning disabilities
- autism
- liver and kidney disease
- digestive system diseases and symptoms
- diabetes
- neurological diseases (including dementia)
- movement disorders
The Hannah Poling affair
If the child has a mitochondrial enzyme deficiency, the vaccines can cause developmental declines.
Biomedical specialists believe that mitochondrial problems can be very common in autism; however, there are treatments that can improve mitochondrial disorders.
It would be nice if mitochondrial testing could become part of normal neonatal screening to find out which babies may be more sensitive to heavy metals and chemicals — whether they have “only” mitochondrial dysfunction or mitochondria are functioning completely abnormally — and preventive measures could be taken to protect children.
If the child has a mitochondrial enzyme deficiency, the vaccines can cause developmental declines.
Biomedical specialists believe that mitochondrial problems can be very common in autism; however, there are treatments that can improve mitochondrial disorders.
It would be nice if mitochondrial testing could become part of normal neonatal screening to find out which babies may be more sensitive to heavy metals and chemicals — whether they have “only” mitochondrial dysfunction or mitochondria are functioning completely abnormally — and preventive measures could be taken to protect children.
Related articles:
- Mitochondrial disorder and autism
- Supplements for mitochondrial disorders
Resources
- https://www.sciencedirect.com/science/article/pii/S2352304220300854
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137782/

Genetic disorders and Autism

Many researchers believe that the primary cause of autism are probably genetic disorders. However, it is not possible to find common ground among autistic children living with different genetic diseases. In fact, many known genetic syndromes can have a profound impact on a child’s development and also cause autism similar symptoms, but most children with autism do not have these main genetic disorders.
Here’s a brief explanation of the genetic/neurological conditions that are so far known to result in symptoms of autism:
Fragile X syndrome
This is the most commonly known genetic cause of developmental delay. It has an extremely rare occurrence. The symptoms of Fragile X are quite indistinguishable from autism, although children with Fragile X are more likely to be hyperactive and anxious. Unfortunately, Fragile X usually causes mental impairment, so these children will have to face more challenges in the coming years (most autistic children have a normal mental functions). Fortunately, the vast majority of children with autism have normal X chromosomes.
Fragile X is transmitted by the mother, so the presence of autism, or mental impairment on the mother’s side, would make this diagnosis more likely.
Rett syndrome
The defect in the X chromosome is responsible for this genetic disorder. However, this affects only girls, because boy fetuses with this defect, as a rule, do not survive. Girls with Rett usually look completely normal, develop normally for several months or even years, and then regress. Characteristic hand-squeezing movements appear, as well as other “neuromuscular problems, such as unsteady walking, tremors, and muscle spasms.
Angelman syndrome
This disease is due to a defect in the UBE3A gene. It leads to severe mental retardation, seizures, and spasmodic muscles. Its symptoms are a happy facial expression, unusual laughter and symptoms characteristic of autism
Neurocutaneous disorders
These genetic-based disorders cause the growth of benign tumors in the brain and skin. The two most common are: neurofibromatosis (NF) and tuberous sclerosis (TS). The development of the baby with these disorders usually begins normally. However, when benign tumors begin to grow in the brain, they cause intellectual developmental delays, the child shows psychiatric symptoms, symptoms of autism and may also have seizures. Multiple cream-colored flat spots appear on the skin in the case of NF, or leaf-shaped white spots in the case of TS. A genetic examination and a CT or MRI scan of the brain can provide a diagnosis.
Chromosome mutation 16P11.2
Children with 16p11. 2 deletion syndrome usually have developmental delay and intellectual disability. Characteristics of deletion syndrome include delayed development; intellectual disability; and autism spectrum disorder, which affects communication and social interaction, impaired communication and socialization skills, as well as delayed development of speech and language. This mutation has been found in some children with autism.
Bannayan-Riley-Ruvalcaba syndrome
This extreme disease occurs infrequently. It has been found in very few children with autism. It causes a very large head, increased body size, hemangiomas and small cysts form on the skin.
Smith-Lemli-Opitz syndrome
This disorder develops due to a metabolic defect in cholesterol production. These children usually have a fusion of second and third toes, are characterized by disparate facial features, such as drooping eyelids, small and low-seated ears, or split uvula, small head size and characterized by slow growth.
Fetal alcohol syndrome
This happens when a pregnant woman drinks alcohol as a way of life, which has consequences for the developing nervous system of the fetus. These babies are retarded in development and show different characteristics of autism, especially hyperactivity. They have a characteristic appearance: the groove between the nose and the upper lip, the so-called philtrum, is flat: the upper lip is thin: the eyes are close to each other. The diagnosis is based on known alcohol exposure.
Landau-Kleffner syndrome
The main feature of this syndrome is the development of seizures from the age of three to seven years, as well as language regression. It differs from autism in that social skills usually remain normal, and the loss of language ability occurs much later than in autism.
Although the last two are not genetic diseases, it is also up to a neurologist to determine their presence, as in the case of the other disorders mentioned above.
What remains a question for researchers is whether there is a single underlying genetic cause of autism. No genetic disease has been identified that is present in all children with autism, and is expected to be less and less likely to do so. In fact, it is important to screen for genetic diseases in order to identify the genetic risk in infants and to start treatment and development as early as possible.
Resources
- m B-R, SeoH-S, Ku J-M, et al. Silibinininhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast-cells. Inflammation. Research. 2013;62(11):941-950. doi:10.1007/s00011-013-0640-1.
- ChapowalA. PetasitesStudy Group. Randomisedcontrolled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. BMJ 2002;324:144-6.
- Hayes, N. A. and Foreman, J. C. The activity of compounds extracted from feverfew on histamine release from rat mast-cells. J Pharm Pharmacol1987;39(6):466-470
- Hsieh et al. Baicalein inhibits IL-1ß- and TNF-a-induced inflammatory cytokine production from human mast-cells via regulation of the NF-?B pathway. ClinMolAllergy. 5: 5. 2007.
- TheoharidesTC, Patra P, Boucher W, et al. Chondroitin sulphateinhibits connective tissue mast-cells. British Journal of Pharmacology. 2000;131(6):1039-1049. doi:10.1038/ sj.bjp.0703672.
- Ro JY, Lee BC, Kim JY, et al. Inhibitory mechanism of aloe single component (alprogen) on mediator release in guinea pig lung mast-cells activated with specific antigenantibodyreactions. J PharmacolExpTher. 2000;292:114–121. 73.
- https://www.ncbi.nlm.nih.gov/pubmed/24477254
- https://www.ncbi.nlm.nih.gov/pubmed/28458279
- https://www.ncbi.nlm.nih.gov/pubmed/9421440
- https://www.ncbi.nlm.nih.gov/pubmed/10344773
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315779/